FLOAT for Healthcare PTSS (PTSS FLOAT)
Neural Mechanisms of Floatation-REST Therapy for Post-Traumatic Stress Symptoms in Frontline Healthcare Workers
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Frontline healthcare workers, first responders, and emergency medical personnel are repeatedly exposed to occupational stressors and potentially traumatic events, placing them at elevated risk for post-traumatic stress symptoms (PTSS), burnout, anxiety, and related impairments. Current stress-reduction approaches for healthcare workers often have limited evidence for efficacy or may be difficult to implement in high-demand emergency and healthcare settings. Therefore, rapid, low-burden interventions that are feasible, tolerable, and safe for this population are needed.
Floatation-REST, or Reduced Environmental Stimulation Therapy, is a non-pharmacological intervention that reduces sensory input to the nervous system through the act of floating supine in a pool of warm water saturated with Epsom salt. The float environment is designed to reduce visual, auditory, thermal, tactile, vestibular, and proprioceptive stimulation. Prior studies suggest that Floatation-REST may acutely reduce stress and anxiety-related symptoms, but it has not yet been systematically evaluated in frontline healthcare workers with elevated PTSS.
This single-site, double-arm pilot study will examine the feasibility, tolerability, and safety of two 60-minute sessions of Floatation-REST compared with a documentary-viewing condition in adults ages 18 to 64 with work-related post-traumatic stress symptoms. Up to 30 participants will be recruited, with the goal of retaining 15 completers randomized on a 2:1 basis to Floatation-REST versus comparator condition. Participants will complete two in-person study visits at the Laureate Institute for Brain Research, including self-report questionnaires, blood and saliva collection, functional magnetic resonance imaging scans, and either Floatation-REST or documentary viewing. Follow-up surveys will be completed virtually up to one week after final intervention session.
The primary aim is to evaluate the safety and tolerability of Floatation-REST in this population. Secondary aims will explore whether Floatation-REST is associated with acute changes in PTSS, perceived stress, anxiety, burnout, mood, mindfulness, and moral injury-related distress. Exploratory aims will examine whether changes in brain network connectivity, salivary cortisol, and blood-based proteomic markers may help explain symptom change. Results from this early-stage study will help determine whether Floatation-REST should be further studied as a potential intervention for post-traumatic stress symptoms in frontline healthcare and emergency personnel.
Typ studie
Zápis (Odhadovaný)
Fáze
- Raná fáze 1
Kontakty a umístění
Studijní kontakt
- Jméno: Adrienne Taren, MD, PhD
- Telefonní číslo: 918-340-4116
- E-mail: ataren@laureateinstitute.org
Studijní záloha kontaktů
- Jméno: Emily M Choquette, PhD
- Telefonní číslo: 918-240-2583
- E-mail: echoquette@laureateinstitute.org
Studijní místa
-
-
Oklahoma
-
Tulsa, Oklahoma, Spojené státy, 74136
- Nábor
- Laureate Institute for Brain Research
-
Kontakt:
- LIBR Assessment Team
- Telefonní číslo: 918-502-5100
- E-mail: info@laureateinstitute.org
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
Work-related post-traumatic stress dysfunction as measured by either of the following inclusion pathways:
(A) PTSS Pathway: PCL-5 greater than or equal to 20, OR meets criteria for full or partial PTSD on the MINI International Neuropsychiatric Interview 7 (DSM-V) (Criteria A + at least 2 B-E Criteria) OR (B) Functionally Anchored Pathway: evidence of work-related trauma exposure on the MINI International Neuropsychiatric Interview 7 (DSM-V) (Criterion A) or Life Events Checklist-5, and at least one of the following: Moral Injury and Distress Scale greater than or equal to 27, Sheehan Disability Scale greater than or equal to 5 on at least 1 of the 3 subscales, high or very high level of perceived stress (measured by PhenX Perceived Stress Scale greater than or equal to 16).
- First responder or other emergency medical personnel
- Ability to read, speak and understand English
- Capable of providing consent
Exclusion Criteria:
- History of neurological conditions
- Skin conditions or open wounds
- DSM-5 diagnosis of psychotic spectrum disorders, obsessive-compulsive disorder, bipolar disorder, severe substance use disorder, or eating disorder
- Inability to lay comfortably in a shallow pool of water
- Failure to adhere to "pre-float checklist"
- Breathalyzer test positive for alcohol or a drug-positive urine test
- Unwillingness to provide consent or complete major aspects of protocol
- MRI contraindications
- Unstable medical diagnoses
- Pregnancy
- Evidence of inability to comply with study procedures based on experimenter judgement
- Change in the dose or prescription of a medication within the 6 weeks before enrolling in the study that could affect brain functioning (e.g., anxiolytics, antipsychotics, antidepressants, benzodiazepines, or mood stabilizers)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Floatation-REST
Participants will float supine in a shallow pool for two one-hour sessions approximately seven days apart.
|
Participants float supine in a shallow pool of water saturated with Epsom salt.
The environment is designed to minimize external stimulation via multiple channels including sound, light, and temperature.
|
|
Aktivní komparátor: Documentary Condition
Participants will watch two one-hour documentaries in a relaxing environment approximately seven days apart.
|
Participants will sit in a quiet room and watch a documentary.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Adverse effects
Časové okno: From baseline to post-intervention seven day follow-up
|
Safety will be assessed using adverse events reported directly to study staff and adverse effects reported on the Floatation-REST effects checklist after each Floatation-REST or comparator session.
As a proxy of safety, adverse effects will be calculated for each participant as the number of instances during the study in which the participant reports an increase above mild for any negatively experienced effect on the checklist.
|
From baseline to post-intervention seven day follow-up
|
|
Dropout Rate
Časové okno: Baseline through seven day post-intervention follow up
|
As a proxy for tolerability, dropout rate for each arm = (# of subjects who are withdrawn from the study)/(# participants in specific arm).
|
Baseline through seven day post-intervention follow up
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Burnout Effects of Floatation-REST
Časové okno: Baseline through seven day post-intervention follow up
|
Burnout measured using the MBI-HSS questionnaire after each experimental session and at follow-up time points
|
Baseline through seven day post-intervention follow up
|
|
Perceived Stress Effects of Floatation-REST
Časové okno: Baseline through seven day post-intervention follow up
|
Perceived stress measured using the Perceived Stress Scale after each experimental session and at follow-up time points
|
Baseline through seven day post-intervention follow up
|
|
Moral Injury Effects of Floatation-REST
Časové okno: Baseline through seven day post-intervention follow up
|
Moral injury measured using the Moral Injury and Distress Scale after each experimental session and at follow-up time points
|
Baseline through seven day post-intervention follow up
|
|
Depressive Symptomatology Effects of Floatation-REST
Časové okno: Baseline through seven day post-intervention follow up
|
Depressive symptoms measured using the Quick Inventory of Depressive Symptomatology (QIDS-SR) after each experimental session and at follow-up time points
|
Baseline through seven day post-intervention follow up
|
Spolupracovníci a vyšetřovatelé
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- #20261153
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .